News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Protox Therapeutics Inc. Reports 2008 First Quarter Results
May 14, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
VANCOUVER, May 13 /CNW/ - Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today released first quarter 2008 financial results for the 3 months ended March 31, 2008 (2008 Q1).
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Layoff Tracker
Appia Shuts Down Before Reaching Clinic
August 27, 2025
·
191 min read
·
BioSpace Editorial Staff
Layoffs
Pfizer Cuts 100 From Former Seagen HQ Amid ‘Digital Enablement and Automation’ Push
August 27, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Appia, Former Kite Cell Therapy Collaborator, Shuts Down
August 26, 2025
·
2 min read
·
Tristan Manalac
IPO
Biotech Finally Has an IPO After Months-Long Freeze
August 25, 2025
·
1 min read
·
Annalee Armstrong
